Fitt Insider cover image

Peptides, Performance Retail, and Fitness Wearables

Fitt Insider

00:00

Retatrutide's potential market impact

Joe Vinayor summarizes Andrew Huberman calling retatrutide a potential trillion-dollar drug and Phase III weight-loss results.

Play episode from 00:14
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app